BSEDesi Farms India LtdHighNeutral
Announced Tue, 20 Jan · 22:37 IST

The Board of Directors approved the appointment of Mr. Shrenik Rajiv Karnawat as Chief Financial Officer (CFO) of the company.

Promoter Family Board EntryManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The board approved multiple major items in a single meeting. Mr. Shrenik Rajiv Karnawat was appointed as CFO, Mr. Sunil Kumar Shahi was re-designated from Executive Director to Managing Director and Chairman, and Mr. Ayush Munnalal Sharma was inducted as an Additional Independent Director. Authorised share capital was revised upwards from Rs. 6 crore to Rs. 46 crore. The board approved two large share-swap acquisitions: 100% of SNA Milk and Milk Products Limited (dairy and ice-cream maker, FY24 turnover ~Rs. 33.7 crore) for ~Rs. 305.8 crore, and 100% of DFSU Farmer Connect Private Limited (ice cream and snacks, newly incorporated in Aug 2025) for ~Rs. 247 crore — together worth about Rs. 552.8 crore. Consideration will be discharged by issuing 3.21 crore new equity shares at Rs. 135 each (face value Rs. 10, premium Rs. 125), along with 3% CCPS and 5% CCDs on a preferential basis. The company is also altering its objects clause to formally shift from logistics into the dairy and ice-cream business.

Likely market impact

This is effectively a business transformation — the company is pivoting from logistics to dairy and ice cream through two large acquisitions paid entirely in shares, meaning heavy dilution for existing shareholders. Post-allotment promoter holding will be about 46.85% and public 53.15%. Notably, the new MD is the founder of SNA Milk (one of the targets) and brother of an existing director, making this a related-party transaction that may draw governance attention; existing investors should weigh the dilution against the strategic shift and review the shareholder approval timelines (target completion by 15 March 2026).